HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC cut its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 9.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 8,537 shares of the company's stock after selling 938 shares during the quarter. Allspring Global Investments Holdings LLC's holdings in HCA Healthcare were worth $2,542,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of HCA. Legacy Investment Solutions LLC purchased a new stake in shares of HCA Healthcare in the 3rd quarter valued at $39,000. Activest Wealth Management grew its position in HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company's stock worth $40,000 after purchasing an additional 125 shares during the period. Canoe Financial LP purchased a new stake in shares of HCA Healthcare in the third quarter worth about $41,000. Capital Performance Advisors LLP purchased a new position in HCA Healthcare during the third quarter valued at approximately $41,000. Finally, Pinnacle Bancorp Inc. boosted its holdings in HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock worth $45,000 after buying an additional 50 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Price Performance

HCA Healthcare stock traded up $13.73 during mid-day trading on Tuesday, reaching $333.30. The company had a trading volume of 2,908,628 shares, compared to its average volume of 1,680,467. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The company has a market capitalization of $82.77 billion, a P/E ratio of 15.17, a P/E/G ratio of 1.10 and a beta of 1.64. The stock's 50-day simple moving average is $314.24 and its 200-day simple moving average is $350.33. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the prior year, the firm posted $5.90 earnings per share. On average, equities analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be paid a dividend of $0.72 per share. The ex-dividend date is Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.86%. This is an increase from HCA Healthcare's previous quarterly dividend of $0.66. HCA Healthcare's dividend payout ratio is currently 13.11%.

Insider Activity

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the business's stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the transaction, the senior vice president now owns 15,412 shares in the company, valued at $4,971,757.08. The trade was a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 1.60% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on HCA. Bank of America dropped their price target on shares of HCA Healthcare from $380.00 to $370.00 and set a "buy" rating on the stock in a research note on Monday, January 27th. Oppenheimer boosted their price objective on HCA Healthcare from $390.00 to $400.00 and gave the stock an "outperform" rating in a research note on Monday, October 28th. Royal Bank of Canada reduced their price objective on HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating for the company in a research note on Monday, January 27th. Truist Financial dropped their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a research note on Monday, January 6th. Finally, StockNews.com cut shares of HCA Healthcare from a "strong-buy" rating to a "buy" rating in a research note on Monday, November 4th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, HCA Healthcare has an average rating of "Moderate Buy" and a consensus price target of $385.67.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.